Cervical cancer screening is an essential part of a woman’s routine health Check. This is a way to detect abnormal cervical cells, including precancerous cervical lesions, and early cervical cancers. Both precancerous lesions and early cervical cancers can be treated very successfully. Routine cervical screening can greatly help to reduce both the number of new cervical cancers diagnosed each year and deaths from the disease.

According to the American Cancer Society (ACS) and American College of O&G (ACOG) guideline, for women aged 30-65 years old, HPV DNA & Pap Smears Co-Testing are the preferred method for screening cervical cancer in every 5 years.

The main purpose of screening with the Pap test is to detect abnormal cells that may develop into cancer if left untreated. The Pap test can also find noncancerous conditions, such as infections and inflammation. It can also find cancer cells.

HPV testing is used to look for the presence of high-risk HPV types in cervical cells. These tests can detect HPV infections that cause cell abnormalities, sometimes even before cell abnormalities are evident.

Doctor Consultation

 - Detailed History

Lab Test

 - Pap Smaer

 - HPV DNA Test

Color’s CAP-accredited and CLIA-certified laboratory in California will utilize next-generation sequencing to analyze all samples

English clinical reports will be issued by Color’s U.S. board-certified medical geneticists.